Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

1.1K
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
1.1K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

1.3K
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.3K
Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

844
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
844
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884
Peptic Ulcer01:27

Peptic Ulcer

47
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
47
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

46
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
46

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Timing and Neurological Outcomes in Traumatic Central Cord Syndrome: A Single-Center Retrospective Cohort Study.

Global spine journal·2026
Same author

Multi-omics analysis reveals sex-specific etiology of human muscle weakness following musculoskeletal injury.

BMC medicine·2026
Same author

Antiviral effect of chelerythrine chloride against tick-borne encephalitis virus.

Virology journal·2026
Same author

"YiJinJing, Wohu Pushi" Posture-Voice Therapy for Dysarthria in Parkinson's Disease Patients Following Subthalamic Nucleus Deep Brain Stimulation: A Randomized Controlled Trial.

CNS neuroscience & therapeutics·2025
Same author

Comparison of Single-Stage and Dual-Stage Approaches for Nonunion Repair in the Absence of Evident Infections.

Journal of orthopaedic trauma·2025
Same author

Evolving Frontier: A Review of the Role of Mobile Medical Application Prescribing.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2021

Related Experiment Video

Updated: Apr 29, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.8K

Necrotizing Esophagitis and Bleeding Associated With Cefazolin.

Tyler Barnes1, Shiqing Yan2, Yaman Kaakeh3

  • 1Purdue University, West Lafayette, IN, USA.

The Annals of Pharmacotherapy
|May 22, 2014
PubMed
Summary

Cefazolin treatment can cause rare but serious bleeding complications, including necrotizing esophagitis. Monitor high-risk patients for adverse events during cefazolin therapy.

Keywords:
black esophagusbleedingcefazolin sodiumcoagulopathyhemorrhagehypoprothrombinemiainternational normalized rationecrotizing esophagitisrenal failure

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.0K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

9.4K

Related Experiment Videos

Last Updated: Apr 29, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.8K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.0K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

9.4K

Area of Science:

  • Internal Medicine
  • Pharmacology
  • Gastroenterology

Background:

  • Necrotizing esophagitis is a rare but severe esophageal condition.
  • Cefazolin, a common antibiotic, is generally considered safe, but potential adverse effects require monitoring.
  • Coagulopathy, an abnormality in blood clotting, can increase bleeding risk.

Purpose of the Study:

  • To report a rare case of necrotizing esophagitis linked to cefazolin-induced coagulopathy.
  • To review existing literature on cefazolin-associated bleeding risks.
  • To highlight the importance of monitoring patients on cefazolin therapy.

Main Methods:

  • Case report of a 53-year-old male with septicemia and osteomyelitis treated with intravenous cefazolin.
  • Patient developed necrotizing esophagitis and severe coagulopathy (INR 8.11, PT 89.2 s) on day 15 of treatment.
  • Diagnostic upper-gastrointestinal endoscopy confirmed necrotizing esophagitis; coagulopathy was treated with vitamin K and fresh frozen plasma.

Main Results:

  • The patient's coagulopathy resolved after treatment, with INR decreasing to 1.55 and PT to 17 s.
  • The Naranjo algorithm indicated a "probable" relationship between cefazolin and the adverse events.
  • Literature review suggests a less common but possible association between cefazolin and increased bleeding risk compared to other cephalosporins.

Conclusions:

  • Cefazolin therapy can be associated with rare but severe adverse events like necrotizing esophagitis and coagulopathy.
  • Healthcare providers should monitor high-risk patients for bleeding and other serious complications during cefazolin treatment.
  • Further investigation into the mechanisms of cefazolin-associated coagulopathy is warranted.